Stephen W Webster Nabriva Therapeutics PLC (NBRV) insider trading activity

Stephen W Webster is Director of Nabriva Therapeutics plc. Currently has a direct ownership of 11,447 shares of NBRV, which is worth approximately $4,578. The most recent transaction as insider was on Aug 02, 2022, when has been sold 7,826 shares (Ordinary Shares) at a price of $0.19 per share, resulting in proceeds of $1,487. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11.4K

0% 3M change

0% 12M change

Total Value Held $4,578

Stephen W Webster Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 02 2022	SELL Open market or private sale	$1,487 $0.19 p/Share	7,826 Reduced 40.61%	11,447 Ordinary Shares
Aug 02 2021	SELL Open market or private sale	$932 $1.2 p/Share	777 Reduced 3.88%	19,273 Ordinary Shares
Jul 28 2021	BUY Grant, award, or other acquisition	-	17,500 Added 46.6%	20,050 Ordinary Shares

Also insider at

TCRR

TCR2 THERAPEUTICS INC. Healthcare

Director

NXTC

NextCure, Inc. Healthcare

CGEM

Cullinan Oncology, Inc. Healthcare

GRTS

Gritstone bio, Inc. Healthcare

SWW